Ophthalmic and Topical Dosage Form New Animal Drugs; Cyclosporine Ophthalmic Ointment

Samenvatting

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Schering-Plough Animal Health Corp. The NADA provides for use of cyclosporine ophthalmic ointment for treatment of chronic keratoconjunctivitis sicca in dogs.